PROTAC CDK9 degrader-2
98%
- Product Code: 55789
CAS:
2435721-30-3
| Molecular Weight: | 748.74 g./mol | Molecular Formula: | C₃₉H₃₆N₆O₁₀ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
The PROTAC CDK9 degrader-2 is primarily utilized in targeted protein degradation, a cutting-edge approach in drug discovery and therapeutic development. It functions by selectively degrading cyclin-dependent kinase 9 (CDK9), a protein implicated in various diseases, particularly cancer. By degrading CDK9, it disrupts abnormal cell proliferation and survival pathways, making it a promising candidate for cancer treatment, especially in malignancies where CDK9 overexpression plays a critical role. Additionally, it is being explored in research to better understand the role of CDK9 in transcriptional regulation and its potential as a therapeutic target in other diseases, such as viral infections and inflammatory disorders. Its application extends to preclinical studies, where it serves as a tool to validate CDK9 as a druggable target and to assess the efficacy of protein degradation strategies in disease models.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $956.83 |
+
-
|
| 0.005 | 10-20 days | $2,750.88 |
+
-
|
PROTAC CDK9 degrader-2
The PROTAC CDK9 degrader-2 is primarily utilized in targeted protein degradation, a cutting-edge approach in drug discovery and therapeutic development. It functions by selectively degrading cyclin-dependent kinase 9 (CDK9), a protein implicated in various diseases, particularly cancer. By degrading CDK9, it disrupts abnormal cell proliferation and survival pathways, making it a promising candidate for cancer treatment, especially in malignancies where CDK9 overexpression plays a critical role. Additionally, it is being explored in research to better understand the role of CDK9 in transcriptional regulation and its potential as a therapeutic target in other diseases, such as viral infections and inflammatory disorders. Its application extends to preclinical studies, where it serves as a tool to validate CDK9 as a druggable target and to assess the efficacy of protein degradation strategies in disease models.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :